Clinical Trial Update: JUVÉDERM® VOLUMA® With Lidocaine for Correction of Temple Hollowing in Chinese Population [Phase 3]

View source ↗

Summary

Phase 3 trial update for JUVÉDERM VOLUMA with Lidocaine in Chinese participants assessing temple hollowing; results have been posted following completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Temple Hollowing

Drugs mentioned

• JUVÉDERM VOLUMA with Lidocaine (hyaluronic acid dermal filler)

Snippet

Sponsor: Allergan | Conditions: Temple Hollowing | Phase 3 | Status: COMPLETED | Results posted: 2024-12-12